STOCK TITAN

Artivion to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Artivion, Inc. (NYSE: AORT) announced participation in two investor conferences on November 16 and November 17, 2022. The management team will present at the Stifel 2022 Healthcare Conference on November 16 at 9:10 a.m. ET, with a live webcast available on their website. Additionally, they will hold one-on-one meetings at the Canaccord Genuity MedTech Forum on November 17. Artivion specializes in medical devices for aortic diseases and operates in over 100 countries.

Positive
  • None.
Negative
  • None.

ATLANTA, Nov. 8, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming investor conferences.

Artivion's management team will present at the upcoming Stifel 2022 Healthcare Conference on Wednesday, November 16, 2022 at the Lotte New York Palace. The Company's presentation is scheduled to begin at 9:10a.m. ET. A live webcast can be accessed through Artivion's website, www.artivion.com, on the Investors page. An archived copy of the webcast will be available for 90 days on the same website.

Members of the management team will also host one-on-one meetings at the upcoming Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on Thursday, November 17, 2022. Due to the format of this event no webcast will be available.

About Artivion, Inc.

Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com.

Contacts:




Artivion         

D. Ashley Lee                                                

Executive Vice President &

Chief Financial Officer

Phone: 770-419-3355

Gilmartin Group LLC

Brian Johnston / Lynn Lewis

Phone:  332-895-3222

investors@artivion.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-to-participate-in-upcoming-investor-conferences-301672095.html

SOURCE Artivion, Inc.

FAQ

When will Artivion participate in the Stifel Healthcare Conference?

Artivion will participate in the Stifel Healthcare Conference on November 16, 2022, at 9:10 a.m. ET.

Is there a webcast available for Artivion's presentations?

Yes, a live webcast of Artivion's presentation at the Stifel Conference will be available on their website.

What is the focus of Artivion's business?

Artivion focuses on developing medical devices for cardiac and vascular surgery, specifically targeting aortic diseases.

What date will Artivion hold one-on-one meetings at the Canaccord Genuity Forum?

Artivion will host one-on-one meetings at the Canaccord Genuity Forum on November 17, 2022.

Where is Artivion headquartered?

Artivion is headquartered in suburban Atlanta, Georgia.

Artivion, Inc.

NYSE:AORT

AORT Rankings

AORT Latest News

AORT Stock Data

1.16B
36.71M
5.48%
87.62%
8%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
KENNESAW